Clinical Trial Update: Adrenocorticotropic Hormone (ACTH) Treatment of Nephrotic Range Proteinuria in Diabetic Nephropathy (NRDN) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating adrenocorticotropic hormone (ACTH) for nephrotic-range proteinuria in patients with diabetic nephropathy; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy
• Nephrotic Syndrome

Drugs mentioned

• ACTH (adrenocorticotropic hormone)

Snippet

Sponsor: Southeast Renal Research Institute | Conditions: Diabetic Nephropathy, Nephrotic Syndrome | Phase 4 | Status: COMPLETED